Role of Immunotherapy in Early- and Late-Stage Triple-Negative Breast Cancer

被引：6

作者：

Morganti, Stefania ^{[1
,2
,3
,4
,5
]}

Tolaney, Sara M. ^{[1
,2
,6
]}

机构：

[1] Dana Farber Canc Inst, Med Oncol, Boston, MA USA

[2] Dana Farber Brigham Canc Ctr, Breast Oncol Program, Boston, MA USA

[3] Harvard Med Sch, Boston, MA USA

[4] Broad Inst & Harvard, Boston, MA USA

[5] Univ Milan, Ist Europeo Oncol, Dept Oncol & Hemato Oncol, Milan, Italy

[6] Dana Farber Canc Inst, 450 Brookline Ave, Boston, MA 02215 USA

来源：

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2023年 / 37卷 / 01期

关键词：

TNBC; Breast cancer; Immunotherapy; Biomarkers; PDL1; Immune checkpoint inhibitors; PEMBROLIZUMAB PLUS CHEMOTHERAPY; PHASE-III TRIAL; NEOADJUVANT CHEMOTHERAPY; DOUBLE-BLIND; PLACEBO; ATEZOLIZUMAB; PACLITAXEL; MELANOMA; TNBC;

D O I：

10.1016/j.hoc.2022.08.014

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：133 / 150

页数：18

共 50 条

[1] Immunotherapy for Early-Stage Triple-Negative Breast Cancer
Burstein, Harold J.
NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (21): : 2048 - 2049
[2] Obesity is associated with a late-stage diagnosis in triple-negative breast cancer
Aranda-Gutierrez, A.
Ferrigno, A. S.
Moncada-Madrazo, M.
Gomez-Picos, A.
De la Garza-Ramos, C.
Mesa-Chavez, F.
Diaz-Perez, H.
Cardona, S.
Ortiz-Lopez, R.
Villarreal-Garza, C.
ANNALS OF ONCOLOGY, 2020, 31 : S31 - S31
[3] Advancing immunotherapy for early-stage triple-negative breast cancer
Di Cosimo, Serena
LANCET, 2020, 396 (10257): : 1046 - 1048
[4] Role of Immunotherapy in Triple-Negative Breast Cancer
Keenan, Tanya E.
Tolaney, Sara M.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (04): : 479 - 489
[5] Facts and Hopes in Immunotherapy for Early-Stage Triple-Negative Breast Cancer
Nederlof, Iris
Voorwerk, Leonie
Kok, Marleen
CLINICAL CANCER RESEARCH, 2023, 29 (13) : 2362 - 2370
[6] Role of Platinum in Early-Stage Triple-Negative Breast Cancer
La Belle, Alyssa
Khatib, Jude
Schiemann, William P.
Vinayak, Shaveta
CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2017, 18 (11)
[7] Role of Platinum in Early-Stage Triple-Negative Breast Cancer
Alyssa La Belle
Jude Khatib
William P. Schiemann
Shaveta Vinayak
Current Treatment Options in Oncology, 2017, 18
[8] Expanding the Role for Immunotherapy in Triple-Negative Breast Cancer
Savas, Peter
Loi, Sherene
CANCER CELL, 2020, 37 (05) : 623 - 624
[9] The Role of Immunotherapy in Triple-Negative Breast Cancer (TNBC)
Michaels, Elena
Chen, Nan
Nanda, Rita
CLINICAL BREAST CANCER, 2024, 24 (04) : 263 - 270
[10] Toosendanin, a late-stage autophagy inhibitor, sensitizes triple-negative breast cancer to irinotecan chemotherapy
Shuang Zhang
Yu Dong
Xiuping Chen
Chris Soon Heng TAN
Min Li
Kai Miao
Jia-Hong Lu
Chinese Medicine, 17

← 1 2 3 4 5 →